Neuropsychological functioning of children with sickle cell disease and varying stroke risk levels

2021 ◽  
Author(s):  
Lori A. Catania
2017 ◽  
Vol 12 (6) ◽  
pp. 580-588 ◽  
Author(s):  
Sara Mazzucco ◽  
Marina Diomedi ◽  
Amrana Qureshi ◽  
Laura Sainati ◽  
Soundrie T Padayachee

Background Sickle cell disease (SCD) is one of the most common causes of stroke in children worldwide. Based on the results of the Stroke Prevention Trial in Sickle Cell Anemia (STOP), annual transcranial Doppler ultrasound (TCD) screening for affected children is standard practice. However, the need for TCD surveillance programs could override the accuracy of the screening, affecting the correct stratification of stroke risk and subsequent clinical management of the target population. Aims To shed light on this issue, a systematic review of the literature on TCD screening for children and adolescents with SCD was carried out (CRD42016050549), according to a list of clinically relevant questions, with a particular focus on screening practices in European countries. Quality of the evidence was rated using the grading of recommendations assessment, development and evaluation. Summary of review Thirty-three studies published in English or French were included (5 randomized controlled trials, 8 experimental non-randomized, and 20 observational studies). The quality of the retrieved evidence ranged between low and high, but was rated as moderate or high most of the times. TCD is effective as a screening tool for the primary prevention of stroke in SCD children. There is no high-quality evidence on the effectiveness of alternative screening methods, such as imaging-TCD with or without angle correction or magnetic resonance angiography. No evidence was found on effectiveness of the screening on children on hydroxyurea and with genotypes other than HbSS and HbS/β0. No European data were found on screening rates or adherence of screening practices to the STOP protocol. Conclusions High-quality studies on alternative screening methods that are currently used in real-world practice, and on screening applicability to specific subgroups of patients are urgently needed. Considering the low awareness of the disease in European countries and the lack of data on screening practices and adherence, clinicians need up-to-date guidelines for more uniform and evidence-based surveillance of children with SCD.


2007 ◽  
Vol 93 (2) ◽  
pp. 138-141 ◽  
Author(s):  
Colin R Deane ◽  
David Goss ◽  
Sandra O’Driscoll ◽  
Sarah Mellor ◽  
Keith R E Pohl ◽  
...  

Blood ◽  
2017 ◽  
Vol 130 (Suppl_1) ◽  
pp. 972-972
Author(s):  
Lena Vaclavu ◽  
Lena Vaclavu ◽  
Henri JMM Mutsaerts ◽  
Esben Thade Petersen ◽  
Ed T VanBavel ◽  
...  

Abstract Introduction: Sickle Cell Disease (SCD) is frequently complicated by stroke. Although transcranial Doppler effectively identifies children at risk for stroke, adult patients do not benefit from this test. In SCD, chronic hemolytic anemia leads to cerebral vasodilation, elevated cerebral blood flow (CBF) and subsequently, impaired cerebrovascular reserve (CVR) capacity. CVR represents the maximum increase in CBF in response to metabolic stressors. CVR mapping is a promising imaging biomarker for stroke risk assessment, potentially identifying patients with preclinical hemodynamic impairment. Our laboratory performs CVR mapping by measuring CBF prior to and following maximum cerebral vasodilation with acetazolamide (ACZ). The primary aim of this study was to quantitatively assess CVR in adult patients with SCD compared to healthy controls. Methods: Adult SCD patients (HbSS/HbSβ0) were recruited for this IRB-approved study with ACZ-induced vasodilation and venous blood sampling. Patients with a history of clinically overt stroke were excluded. Controls were selected from patients' friends and family members without SCD and matched on age, sex, and race. The following MRI images were acquired at 3T (Philips Healthcare, Best, NL): time of flight MRA for visualization of major cerebral vessels, T2 FLAIR for manual segmentation of white matter hyperintensities (WMHs), and pseudo-continuous arterial spin labeling (ASL) for CBF assessment. CBF was measured at baseline and 10min post ACZ (16mg/kg intravenous infusion over 3min). MRI images were processed with the ExploreASL toolbox, to obtain registered maps of quantified CBF and CVR (% change in CBF). We measured T1blood in each subject to improve quantification accuracy as these values can differ in SCD. Group comparisons were performed using non-parametric two-sample tests. Correlations were characterized by Spearman's rho (ρ). P<0.05 was considered significant. Median values with interquartile range (IQR) are reported for non-normally distributed variables, otherwise mean and standard deviation are reported. Results: 30 patients with SCD (mean age 33±12y,19M) and 11 controls (mean age 37±15y, 6M) were included in this cross-sectional controlled cohort study. Mean hemoglobin levels in patients with SCD were 8.8±1.4 g/dL and in healthy controls were 13.7±1.3 g/dL. Patients with SCD had higher baseline CBF compared to healthy controls (median 73(IQR:25) vs 42(IQR:6) mL/100g/min, p<0.001, F1a). CBF was inversely related to hemoglobin (ρ=-0.84, p<0.001, F1b). ACZ elicited an increase in CBF(p<0.001) which was similar in magnitude in both groups (patients 29±16, controls 35±11, mL/100g/min, F1c), resulting in a lower mean CVR in patients compared to controls (41±24% vs 81±27%, p<0.001, F1d). Baseline CBF predicted CVR (ρ=-0.68, p<0.001, F1e). WMHs were present in both groups, and WMH volume correlated with age (ρ = 0.54, p<0.001). There were no statistical associations between WMH volume and CVR (ρ = -0.15, p=0.4) or CBF(ρ = 0.02, p=0.9), however, two patients with the largest WMH volume (>6 mL) had the lowest CVR (<20%). Discussion: This study shows that regional CVR can be measured using ASL-MRI with ACZ challenge. ACZ was well-tolerated and elicited a robust cerebrovasodilatory response in both groups. However, the relative increase in oxygen delivery (CVR) was much lower in SCD patients, which suggests that patients with SCD have nearly maximal cerebrovascular dilation at baseline. Our data suggest that chronic vasodilation due to anaemia has let to outward remodelling of vessels in adult patients, permitting a larger vascular bed to compensate their anemia. Our premise is that resting O2 delivery is normal in SCD patients; we showed that increasing CBF overcomes severe anemia. However, high resting CBF limits the brain's ability to recruit additional O2 under times of stress. SCD patients have many transient interruptions in O2 delivery including aplastic crisis, splenic sequestration and sleep apnea, as well as metabolic stressors such as fever, sickle cell crisis, infection, and seizure. While baseline CBF predicted global CVR, ASL provides information regarding regional O2 delivery that may offer insight into distribution of ischemic white matter damage. Further study is needed to determine the impact of blood transfusions and hydroxyurea on CVR and whether there is a critical CVR threshold that predicts stroke risk. Disclosures No relevant conflicts of interest to declare.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 4692-4692 ◽  
Author(s):  
Sofia Galli ◽  
Soundrie Padayachee ◽  
Jo Howard

Background Unlike in children, Transcranial Doppler Ultrasound (TCD) can not currently be used to predict stroke risk in adults with Sickle Cell Disease, and this is confounded by an age related decline in TCD and lack of an established normal TCD velocity range for adults. In addition abnormalities in the extracranial circulation have been associated with increased incidence of stroke in children with SCD, but this has not been shown in adults. Aims To retrospectively review TCD and carotid duplex ultrasound results from adults with SCD and to correlate with neurological outcome. Methods TCD and carotid duplex data were collected from 112 patients from January 2003 to December 2012 and analysed retrospectively. Imaging and non-imaging TCD and carotid duplex were performed as a routine out-patient investigation as part of an annual review in the comprehensive adult sickle cell clinic in our unit. STOP velocity criteria were used for stroke risk stratification. Carotid disease was defined as non-significant (<50%), moderate stenosis (50-69%) and severe disease (≥70%). Results The mean age of patients was 35.4 (range 17-79) years; 65% were female and 78% had HbSS. There were 5 patient exclusions based on the TCD findings; two were non-diagnostic and three had abnormal scans as part of childhood screening. The remaining 107 patients were divided into two groups; Group I patients had a normal neurological examination (n = 95) and Group II had an abnormal neurological examination with a clinical diagnosis of stroke that preceded TCD/carotid duplex examination (n = 12). In Group I there were 4 abnormal TCD scans according to STOP criteria; two showed significant asymmetry (>25%) and two showed abnormally low velocities (<50cm/s), one of whom subsequently developed a silent stroke. Although the remaining 91 patients had normal TCD findings; a limited TCD examination was noted in 6 patients and asymmetrical velocities that fell below the 25% threshold were observed in 7 patients, one of whom subsequently developed a symptomatic lacunar infarct. A further eight patients showed extracranial (ICA) disease and one of these also had evidence of a silent stroke on MRI. In Group II, 5 patients showed abnormal TCD findings; four had low velocities (<50cm/sec) and one had low velocities and significant asymmetry. Six patients had severe extracranial ICA stenosis or occlusion on carotid duplex. There was a significant increase in the incidence of abnormal TCD (C2=19.4, p<0.001) and duplex findings (C2=16.2, p<0.001) in patients in Group II compared to Group I. Conclusions Routine screening of adults with SCD using TCD did not show any asymptomatic patients with elevated TCD flow-velocities (>170cm/s), confirming previous studies. However, other abnormal ultrasound findings were observed including; abnormally low or asymmetric TCD velocities and extracranial ICA disease. These abnormalities were associated with stroke in three cases; TCD asymmetry preceded a lacunar infarct by five years, abnormally low velocities preceded a silent infarct by two years and severe extracranial ICA stenosis was associated with a silent infarct. There was a significantly increased incidence of abnormal ultrasound findings in patients who had neurological symptoms (91.6% versus 12.6%). Further investigation of the incidence and implications of abnormal TCD and extracranial carotid duplex findings in adults with sickle cell disease is required. Longitudinal follow-up of patients with low or asymmetric velocities and ICA disease will clarify if these abnormalities are associated with increased neurological morbidity; if so, intervention may be justified. The traditional STOP criteria of raised TCD velocities are inadequate in the adult sickle population, new velocity criteria are required to stratify the risk of stroke in this population. Disclosures: Howard: Sangart: Membership on an entity’s Board of Directors or advisory committees.


2006 ◽  
Vol 209 (2) ◽  
pp. 135-140 ◽  
Author(s):  
Ismet Melek ◽  
Ferit Akgul ◽  
Taskin Duman ◽  
Fatih Yalcin ◽  
Edip Gali

Sign in / Sign up

Export Citation Format

Share Document